Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment

Cutaneous melanoma arises from the malignant transformation of skin melanocytes; its incidence and mortality have been increasing steadily over the last 50 years, now representing 3% of total tumors. Once melanoma metastasizes, prognosis is somber and therapeutic options are limited. However, the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Aris, Mariana, Barrio, María Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321613/
https://www.ncbi.nlm.nih.gov/pubmed/25709607
http://dx.doi.org/10.3389/fimmu.2015.00046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4321613/
https://www.ncbi.nlm.nih.gov/pubmed/25709607
http://dx.doi.org/10.3389/fimmu.2015.00046

Ejemplares similares